Disc Medicine (IRON) Competitors $59.94 -0.40 (-0.66%) Closing price 04:00 PM EasternExtended Trading$59.98 +0.04 (+0.07%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IRON vs. ROIV, RVMD, GRFS, RYTM, LEGN, ABVX, AXSM, RNA, NUVL, and MRUSShould you be buying Disc Medicine stock or one of its competitors? The main competitors of Disc Medicine include Roivant Sciences (ROIV), Revolution Medicines (RVMD), Grifols (GRFS), Rhythm Pharmaceuticals (RYTM), Legend Biotech (LEGN), Abivax (ABVX), Axsome Therapeutics (AXSM), Avidity Biosciences (RNA), Nuvalent (NUVL), and Merus (MRUS). These companies are all part of the "pharmaceutical products" industry. Disc Medicine vs. Its Competitors Roivant Sciences Revolution Medicines Grifols Rhythm Pharmaceuticals Legend Biotech Abivax Axsome Therapeutics Avidity Biosciences Nuvalent Merus Roivant Sciences (NASDAQ:ROIV) and Disc Medicine (NASDAQ:IRON) are both mid-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, valuation, media sentiment, analyst recommendations, profitability, earnings, dividends and institutional ownership. Do insiders and institutionals believe in ROIV or IRON? 64.8% of Roivant Sciences shares are owned by institutional investors. Comparatively, 83.7% of Disc Medicine shares are owned by institutional investors. 10.8% of Roivant Sciences shares are owned by insiders. Comparatively, 3.6% of Disc Medicine shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more volatility and risk, ROIV or IRON? Roivant Sciences has a beta of 1.15, suggesting that its stock price is 15% more volatile than the S&P 500. Comparatively, Disc Medicine has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500. Is ROIV or IRON more profitable? Disc Medicine has a net margin of 0.00% compared to Roivant Sciences' net margin of -2,111.79%. Roivant Sciences' return on equity of -15.90% beat Disc Medicine's return on equity.Company Net Margins Return on Equity Return on Assets Roivant Sciences-2,111.79% -15.90% -14.95% Disc Medicine N/A -26.60%-24.58% Does the media refer more to ROIV or IRON? In the previous week, Roivant Sciences had 13 more articles in the media than Disc Medicine. MarketBeat recorded 21 mentions for Roivant Sciences and 8 mentions for Disc Medicine. Disc Medicine's average media sentiment score of 1.68 beat Roivant Sciences' score of 0.72 indicating that Disc Medicine is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Roivant Sciences 9 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Disc Medicine 7 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Do analysts rate ROIV or IRON? Roivant Sciences currently has a consensus target price of $16.38, indicating a potential upside of 18.92%. Disc Medicine has a consensus target price of $98.30, indicating a potential upside of 64.00%. Given Disc Medicine's higher probable upside, analysts clearly believe Disc Medicine is more favorable than Roivant Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Roivant Sciences 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.20Disc Medicine 0 Sell rating(s) 0 Hold rating(s) 10 Buy rating(s) 1 Strong Buy rating(s) 3.09 Which has higher valuation & earnings, ROIV or IRON? Disc Medicine has lower revenue, but higher earnings than Roivant Sciences. Roivant Sciences is trading at a lower price-to-earnings ratio than Disc Medicine, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRoivant Sciences$29.05M323.69-$171.98M-$0.70-19.67Disc MedicineN/AN/A-$109.36M-$4.47-13.41 SummaryRoivant Sciences beats Disc Medicine on 9 of the 16 factors compared between the two stocks. Get Disc Medicine News Delivered to You Automatically Sign up to receive the latest news and ratings for IRON and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding IRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart IRON vs. The Competition Export to ExcelMetricDisc MedicineMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.08B$3.15B$5.76B$10.03BDividend YieldN/A2.28%5.28%4.52%P/E Ratio-13.4121.4575.4326.15Price / SalesN/A427.65515.98171.98Price / CashN/A45.5837.2059.76Price / Book4.049.5911.536.20Net Income-$109.36M-$53.33M$3.28B$270.56M7 Day Performance-2.68%0.61%0.42%2.70%1 Month Performance3.29%11.09%10.81%8.77%1 Year Performance20.99%12.67%61.62%27.50% Disc Medicine Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)IRONDisc Medicine2.6868 of 5 stars$59.94-0.7%$98.30+64.0%+16.6%$2.08BN/A-13.4130Positive NewsROIVRoivant Sciences2.7688 of 5 stars$11.93-0.1%$16.50+38.3%+7.8%$8.15B$29.05M-17.04860News CoveragePositive NewsOptions VolumeRVMDRevolution Medicines4.2663 of 5 stars$37.97-0.9%$69.92+84.2%-2.8%$7.10B$11.58M-8.44250GRFSGrifols4.1868 of 5 stars$9.97+1.0%$10.30+3.3%+15.3%$6.85B$7.81B8.5223,822News CoveragePositive NewsRYTMRhythm Pharmaceuticals3.1044 of 5 stars$103.15-1.0%$101.57-1.5%+100.2%$6.85B$130.13M-34.27140Positive NewsLEGNLegend Biotech3.4588 of 5 stars$34.73+1.0%$74.22+113.7%-32.0%$6.41B$627.24M-39.472,609ABVXAbivax2.7334 of 5 stars$81.03-0.7%$92.33+13.9%+643.8%$6.12BN/A0.0061News CoveragePositive NewsEarnings ReportAnalyst ForecastAXSMAxsome Therapeutics4.7488 of 5 stars$121.28-0.4%$178.00+46.8%+33.6%$6.05B$385.69M-23.92380Positive NewsInsider TradeRNAAvidity Biosciences2.391 of 5 stars$46.58-4.1%$67.00+43.8%+14.4%$5.99B$10.90M-13.08190News CoverageAnalyst ForecastInsider TradeNUVLNuvalent2.6827 of 5 stars$76.58+0.7%$120.80+57.7%-11.8%$5.52BN/A-15.6340Analyst ForecastMRUSMerus3.141 of 5 stars$65.84-0.4%$88.75+34.8%+36.7%$4.98B$36.13M-11.9737Positive News Related Companies and Tools Related Companies Roivant Sciences Alternatives Revolution Medicines Alternatives Grifols Alternatives Rhythm Pharmaceuticals Alternatives Legend Biotech Alternatives Abivax Alternatives Axsome Therapeutics Alternatives Avidity Biosciences Alternatives Nuvalent Alternatives Merus Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:IRON) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersThis stock just surpassed PalantirThe media hasn't caught up to the story yet, but when they do, this stock could leave Nvidia in the dust. I...InvestorPlace | SponsoredOne tiny company just cracked Google’s $19B problemTucked away outside San Antonio sits a facility most Americans don’t know exists. It’s not mining gold or o...True Market Insiders | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredTrump’s reported death a hoaxHow Trump’s latest policies could trigger a full-scale debt collapse… And the specific investments that cou...Porter & Company | SponsoredWorld War 3? Everything Just Changed — and One Tiny Company Is at the Center of It.Trump immediately activated a $5.3 TRILLION AI missile shield — code-named Golden Dome — to stop drone swarms ...Angel Publishing | SponsoredLitecoin’s Creator Backs the World’s First TreasuryBitcoin's corporate adoption story has been written. Litecoin's is just beginning.The Tomorrow Investor | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Disc Medicine, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Disc Medicine With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IRON Stock Alerts